Acadian Asset Management
INDV icon

Acadian Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Acadian Asset Management’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.4M Sell
1,391,612
-1,693,501
-55% -$55.9M 0.06% 256
2025
Q4 		$110M Buy
3,085,113
+201,653
+7% +$6.16M 0.18% 113
2025
Q3 		$69M Buy
2,883,460
+1,391,188
+93% +$29.1M 0.12% 160
2025
Q2 		$22M Buy
1,492,272
+827,230
+124% +$9.63M 0.05% 296
2025
Q1 		$6.33M Buy
+665,042
New +$6.99M 0.02% 431
2024
Q3 		– Sell
-277,197
Closed -$4.34M – 2203
2024
Q2 		$4.34M Sell
277,197
-898,260
-76% -$16.2M 0.01% 539
2024
Q1 		$25.1M Sell
1,175,457
-468,602
-29% -$8.8M 0.09% 183
2023
Q4 		$24.8M Sell
1,644,059
-637,120
-28% -$11.3M 0.1% 183
2023
Q3 		$49.5M Sell
2,281,179
-47,527
-2% -$1.08M 0.21% 126
2023
Q2 		$54M Buy
+2,328,706
New +$53.4M 0.22% 124

Other funds holding INDV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management's INDV Position: Q1 2026 in Review

Acadian Asset Management reduced its Indivior Pharmaceuticals (INDV) stake by 55% in Q1 2026, selling an estimated $55.9M and leaving 1,391,612 shares worth $42.4M. The position accounts for 0.06% of the portfolio, ranked #256.

Acadian Asset Management first reported a position in INDV in Q2 2023 and has held it in 10 quarters since. The position peaked at $110M in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Acadian Asset Management held 1,391,612 shares of Indivior Pharmaceuticals worth $42.4M as of Q1 2026.
  • Acadian Asset Management sold 1,693,501 Indivior Pharmaceuticals shares in Q1 2026, an estimated $55.9M.
  • Indivior Pharmaceuticals made up 0.06% of Acadian Asset Management's portfolio in Q1 2026, its #256 holding.
  • Acadian Asset Management first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 10 quarters since.
  • Acadian Asset Management's Indivior Pharmaceuticals position peaked at $110M in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.